Biography and Research Information
OverviewAI-generated summary
Joshua Walls' research has focused on several areas within health sciences. His publications include an examination of acute inflammatory demyelinating polyneuropathy as an initial symptom of COVID-19 infection. He has also investigated asthma definitions and their comparative outcomes, utilizing both HEDIS persistent asthma criteria and a non-restrictive model. Additionally, Walls has studied thunderstorm asthma within the context of seasonal allergic rhinitis through the TAISAR study.
Walls collaborates with researchers at the University of Arkansas for Medical Sciences, including Akilah A. Jefferson, Joshua Walls, Mandana Rezaeiahari, and J. Mick Tilford, with whom he has co-authored multiple publications.
Metrics
- Publications: 2
Selected Publications
-
Comparing Outcomes between HEDIS Persistent Asthma Definition and a Non-Restrictive Model (2023)
-
Acute Inflammatory Demyelinating Polyneuropathy as the first presenting feature of COVID 19 infection (P9-12.003) (2022)
Collaboration Network
Top Collaborators
- Thunderstorm Asthma in Seasonal Allergic Rhinitis: The TAISAR Study
- Comparing Outcomes between HEDIS Persistent Asthma Definition and a Non-Restrictive Model
- Comparing Outcomes between HEDIS Persistent Asthma Definition and a Non-Restrictive Model
- Comparing Outcomes between HEDIS Persistent Asthma Definition and a Non-Restrictive Model
- Comparing Outcomes between HEDIS Persistent Asthma Definition and a Non-Restrictive Model
- Comparing Outcomes between HEDIS Persistent Asthma Definition and a Non-Restrictive Model
- Comparing Outcomes between HEDIS Persistent Asthma Definition and a Non-Restrictive Model
- Comparing Outcomes between HEDIS Persistent Asthma Definition and a Non-Restrictive Model
- Acute Inflammatory Demyelinating Polyneuropathy as the first presenting feature of COVID 19 infection (P9-12.003)
- Acute Inflammatory Demyelinating Polyneuropathy as the first presenting feature of COVID 19 infection (P9-12.003)
- Acute Inflammatory Demyelinating Polyneuropathy as the first presenting feature of COVID 19 infection (P9-12.003)
- Acute Inflammatory Demyelinating Polyneuropathy as the first presenting feature of COVID 19 infection (P9-12.003)
Similar Researchers
Based on overlapping research topics